[A case of remnant gastric cancer responding to neoadjuvant TS-1 therapy]

Y Deguchi; A Nashimoto; H Yabusaki; O Tanaka; J Sasaki

[A case of remnant gastric cancer responding to neoadjuvant TS-1 therapy]

Gan To Kagaku Ryoho. 2001 Oct;28(10):1449-52.

[Article in Japanese]

Authors

Y Deguchi¹, A Nashimoto, H Yabusaki, O Tanaka, J Sasaki

Affiliation

¹ Dept. of Surgery, Niigata Cancer Center Hospital.

PMID: 11681256

Abstract

We report the case a 77-year-old male with remnant gastric cancer successfully treated with TS-1 as neoadjuvant chemotherapy. His treatment was daily oral administration of 100 mg TS-1 for 28 days. This therapy was safely carried out on an outpatient basis. The histological diagnosis of the resected stomach revealed complete disappearance of cancer cells in the stomach and the regional lymph nodes. This case suggests that TS-1 may have a potent therapeutic effect in neoadjuvant chemotherapy for recurrent gastric cancer.

Publication types

Case Reports
English Abstract

MeSH terms

Administration, Oral
Aged
Antimetabolites, Antineoplastic / therapeutic use*
Carcinoma, Signet Ring Cell / drug therapy*
Carcinoma, Signet Ring Cell / surgery
Drug Administration Schedule
Drug Combinations
Gastric Stump*
Humans
Male
Neoadjuvant Therapy
Oxonic Acid / therapeutic use*
Pyridines / therapeutic use*
Stomach Neoplasms / drug therapy*
Stomach Neoplasms / surgery
Tegafur / therapeutic use*

Substances

Antimetabolites, Antineoplastic
Drug Combinations
Pyridines
S 1 (combination)
Tegafur
Oxonic Acid